学术探索
学术期刊
新闻热点
数据分析
智能评审

BIOLOGICAL RESPONSE MODIFIERS IN MELANOMA

被引：12
作者：
BRIDGEWATER, JA
GORE, ME
机构：
[1] Department of Medicine, Royal Marsden Hospital, London
来源：
BRITISH MEDICAL BULLETIN | 1995年 / 51卷 / 03期
关键词：
D O I：
10.1093/oxfordjournals.bmb.a072985
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：656 / 677
页数：22
相关论文
共 94 条
[51]   INTERLEUKIN-2-INDUCED THYROID-DYSFUNCTION IS CORRELATED WITH TREATMENT DURATION BUT NOT WITH TUMOR RESPONSE [J].
KRUIT, WHJ ;
BOLHUIS, RLH ;
GOEY, SH ;
JANSEN, RLH ;
EGGERMONT, AMM ;
BATCHELOR, D ;
SCHMITZ, PIM ;
STOTER, G .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) :921-924
[52]   TRENDS OF CANCER MORTALITY IN EUROPE, 1955-1989 .2. RESPIRATORY-TRACT, BONE, CONNECTIVE AND SOFT-TISSUE SARCOMAS, AND SKIN [J].
LAVECCHIA, C ;
LUCCHINI, F ;
NEGRI, E ;
BOYLE, P ;
MAISONNEUVE, P ;
LEVI, F .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :514-599
[53]   REPEATED ANTITUMOUR ANTIBODY THERAPY IN MAN WITH SUPPRESSION OF THE HOST RESPONSE BY CYCLOSPORINE-A [J].
LEDERMANN, JA ;
BEGENT, RHJ ;
BAGSHAWE, KD ;
RIGGS, SJ ;
SEARLE, F ;
GLASER, MG ;
GREEN, AJ ;
DALE, RG .
BRITISH JOURNAL OF CANCER, 1988, 58 (05) :654-657
[54]   CONCOMITANT ADMINISTRATION OF RECOMBINANT HUMAN INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA-2A IN CANCER-PATIENTS - A PHASE-I STUDY [J].
LEE, KH ;
TALPAZ, M ;
ROTHBERG, JM ;
MURRAY, JL ;
PAPADOPOULOS, N ;
PLAGER, C ;
BENJAMIN, R ;
LEVITT, D ;
GUTTERMAN, J .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) :1726-1732
[55]  
LEGHA SS, 1993, SEMIN ONCOL, V20, P27
[56]   CLINICAL-EVALUATION OF RECOMBINANT INTERFERON ALFA-2A (ROFERON-A) IN METASTATIC MELANOMA USING 2 DIFFERENT SCHEDULES [J].
LEGHA, SS ;
PAPADOPOULOS, NEJ ;
PLAGER, C ;
RING, S ;
CHAWLA, SP ;
EVANS, LM ;
BENJAMIN, RS .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) :1240-1246
[57]  
LEGHA SS, 1987, J CLIN ONCOL, V5, P1858
[58]  
MACKIE RM, 1993, CURR OPIN ONCOL, V5, P353
[59]   PHASE-II STUDIES OF RECOMBINANT HUMAN INTERLEUKIN-4 IN ADVANCED RENAL-CANCER AND MALIGNANT-MELANOMA [J].
MARGOLIN, K ;
ARONSON, FR ;
SZNOL, M ;
ATKINS, MB ;
GUCALP, R ;
FISHER, RI ;
SUNDERLAND, M ;
DOROSHOW, JH ;
ERNEST, ML ;
MIER, JW ;
DUTCHER, JP ;
GAYNOR, ER ;
WEISS, GR .
JOURNAL OF IMMUNOTHERAPY, 1994, 15 (02) :147-153
[60]  
MCLEOD GR, 1990, J INVEST DERMATOL S, V95, P6
12345678910